13D/13G Filings - INOVIO PHARMACEUTICALS INC. (INO)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-10
11:04 am
Purchase
2020-12-3113GInovio Pharmaceuticals, Inc.
INO
VANGUARD GROUP INC765,470
5.420%
344,437increase
(+81.81%)
Filing
History
2021-02-10
08:52 am
Purchase
2020-12-3113GInovio Pharmaceuticals, Inc.
INO
STATE STREET CORP
STT
741,213
5.250%
741,213increase
(New Position)
Filing
History
2021-02-05
06:10 am
Sale
2020-12-3113GInovio Pharmaceuticals, Inc.
INO
Sumitomo Mitsui Trust Group Inc.0
0.000%
-420,634decrease
(Position Closed)
Filing
History
2021-01-29
09:57 am
Purchase
2020-12-3113GInovio Pharmaceuticals, Inc.
INO
BlackRock Inc.
BLK
1,186,912
8.400%
550,695increase
(+86.56%)
Filing
History
Goto Prev, 0, 1